Steven Bollipo

Steven Bollipo

Auto-generated profile, based on publicly available information

Steven Bollipo

School of Medicine & Public Health, The University of Newcastle, Callaghan, New South Wales, Australia

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2020 in Liver International
Verified
Journal Article
Open access
PDF file
Yasser FouadYasser Fouad
Yasser Fouad
IWImam Waked
Imam Waked
SBSteven Bollipo
Steven Bollipo
AGAhmed Gomaa
Ahmed Gomaa
YAYousef Ajlouni
Yousef Ajlouni
DADina Attia
Dina Attia
In medicine, language matters and the words used to name and describe a disease can have a profound impact on patients and their families. Over the last two decades, many criticisms have been voiced about the nomenclature and definition of non‐alcoholic fatty liver disease (NAFLD) in regards not only to the prominent role that alcohol plays in the definition but also on the negative impacts of the nomenclature including trivialization, stigmatization and less consideration of the disease in health policy. Recently, a consensus of international experts proposed that the disease acronym be changed from NAFLD to metabolic (dysfunction) associated fatty liver disease or ‘MAFLD’. This change goes far beyond a mere semantic revision and may be the first step that catalyses the process to better conceptualize the disease for health promotion, patient orientation, case identification, ongoing clinical trials and for health services delivery. Here we review the history of, and definitions of MAFLD in the context of advancing our understanding of the pathogenesis of the disease. We also address the reasons, signals, promises, challenges and the way going forward from the name change from various stakeholder perspectives.

31 March 2020 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Open access
PDF file
Rashid Nok Shun LuiRashid Nok Shun Lui
Rashid Nok Shun Lui
SWSunny Wong
Sunny Wong
SSSergio A Sánchez‐Luna
Sergio A Sánchez‐Luna
GPGianluca Pellino
Gianluca Pellino
SBSteven Bollipo
Steven Bollipo
JSJoseph JY Sung
Joseph JY Sung
From its beginning in December 2019, the coronavirus disease 2019 outbreak has spread globally from Wuhan and is now declared a pandemic by the World Health Organization. The sheer scale and severity of this pandemic is unprecedented in the modern era. Although primarily a respiratory tract infection transmitted by direct contact and droplets, during aerosol‐generating procedures, there is a possibility of airborne transmission. In addition, emerging evidence suggests possible fecal–oral spread of the virus. Clinical departments that perform endoscopy are faced with daunting challenges during this pandemic. To date, multiple position statements and guidelines have been issued by various professional organizations to recommend practices in endoscopic procedures. This article aims to summarize and discuss available evidence for these practices, to provide guidance for endoscopy to enhance patient safety, avoid nosocomial outbreaks, protect healthcare personnel, and ensure rational use of personal protective equipment. Responses adapted to national recommendations and local infection control guidelines and tailored to the availability of medical resources are imminently needed to fight the coronavirus disease 2019 pandemic.

1 October 2020 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
KPKatarzyna M. Pawlak
Katarzyna M. Pawlak
JKJan Kral
Jan Kral
RKRishad Khan
Rishad Khan
SASunil Amin
Sunil Amin
MBMohammad Bilal
Mohammad Bilal
KSKeith Siau
Keith Siau

1 March 1998 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
RBRg Batey
Rg Batey
ABA Bensoussan
A Bensoussan
YFYang Yi Fan
Yang Yi Fan
SBS Bollipo
S Bollipo
MHMa Hossain
Ma Hossain

4 June 2020 in Gut
Verified
Journal Article
Open access
PDF file
SBSteven Bollipo
Steven Bollipo
DKDevika Kapuria
Devika Kapuria
ARAtoosa Rabiee
Atoosa Rabiee
GBGil Ben-Yakov
Gil Ben-Yakov
Rashid Nok Shun LuiRashid Nok Shun Lui
Rashid Nok Shun Lui
RDRenumathy Dhanasekaran
Renumathy Dhanasekaran
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the current global pandemic of COVID-19, which is associated with significant morbidity and mortality.1 As of 26 April 2020, it has infected over three million people worldwide and caused more than 200 000 deaths.2 Chronic liver diseases from HCV, HBV, alcoholism or non-alcoholic fatty liver disease (NAFLD) represent a major disease burden in the world. Around 1.5 billion people have chronic liver diseases worldwide, and it causes around two million deaths per year. While self-resolving elevations of transaminases are reported in 15%–54% of patients with COVID-19, those with more severe disease experience worse liver injury.3–5 An open international registry, SECURE-Cirrhosis, is reporting a mortality rate of 40% among the 118 patients with cirrhosis.6 Thus, patients with chronic liver disease represent a vulnerable population who are at higher risk of acquiring COVID-19 and suffering from its complications.7 8

1 December 2021 in Clinical and Experimental Gastroenterology
Verified
Journal Article
Open access
PDF file
OBOliver Bendall
Oliver Bendall
JJJoel James
Joel James
KPKatarzyna Monika Pawlak
Katarzyna Monika Pawlak
SISauid Ishaq
Sauid Ishaq
JTJ Andy Tau
J Andy Tau
KSKeith Siau
Keith Siau
Delayed post-polypectomy bleeding (DPPB) is a potentially severe complication of therapeutic colonoscopy which can result in hospital readmission and re-intervention. Over the last decade, rates of DPPB reported in the literature have fallen from over 2% to 0.3– 1.2%, largely due to improvements in resection technique, a shift towards cold snare polypectomy, better training, adherence to guidelines on periprocedural antithrombotic management, and the use of antithrombotics with more favourable bleeding profiles. However, as the complexity of polypectomy undertaken worldwide increases, so does the importance of identifying patients at increased risk of DPPB. Risk factors can be categorised according to patient, polyp and personnel related factors, and their integration together to provide an individualised risk score is an evolving field. Strategies to reduce DPPB include safe practices relevant to all patients undergoing colonoscopy, as well as specific considerations for patients identified to be high risk. This narrative review sets out an evidence-based summary of factors that contribute to the risk of DPPB before discussing pragmatic interventions to mitigate their risk and improve patient safety.